Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04781673 · ClinicalTrials.gov registry record · Phase 4
Ketamine vs Lidocaine in Traumatic Rib Fractures
A Phase 4 study of Rib Fractures and Rib Fracture Multiple, sponsored by Brittany Hoyte.
- Active
- Registry status
- Phase 4
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT04781673 is a Phase 4 study of Rib Fractures and Rib Fracture Multiple that is active but no longer recruiting, run by Brittany Hoyte. The registered enrollment target is 74 participants, below the 93-participant average among 9 other Rib Fractures trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04781673, a Phase 4 study of Rib Fractures and Rib Fracture Multiple, is active but no longer recruiting, sponsored by Brittany Hoyte.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
Rib fractures continue to be a common occurrence in trauma patients of all ages. Traumatic rib fractures can cause severe pain in patients and lead to shallow breathing and further complications such as the need for mechanical ventilation, hospital or ventilator associated pneumonia, atelectasis, and acute respiratory distress syndrome. Effective multimodal pain management is needed to optimize a patient's respiratory status and can also play a role in early mobility, less pulmonary complications, shorter ICU and hospital length of stay, and decreased mortality. Current multimodal pain management options include opioids, muscle relaxants, gabapentin, acetaminophen, nonsteroidal anti-inflammatory drugs, and various regional/neuraxial anesthesia techniques. Both ketamine and lidocaine infusions for pain control have also been shown in studies to be safe and effective, with the benefit of minimizing the use of opioids. However, there have been very few studies that have used ketamine or lidocaine infusions for pain control specifically in patients with traumatic rib fractures. Therefore, the purpose of this study is to evaluate ketamine versus lidocaine infusions as an adjunctive therapy to reduce opioid consumption in the first 72 hours in patients with multiple traumatic rib fractures.
Conditions Studied
Interventions
- DRUG Ketamine
- DRUG Lidocaine
Study Locations (1)
Michigan
- Corewell Health West - Grand Rapids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2026-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04781673
The ClinicalTrials.gov registry entry for NCT04781673 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 93-participant average among 9 other Rib Fractures trials with a reported enrollment target (20% lower). The listed sponsor is Brittany Hoyte, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Rib Fractures appearing as the primary indexed condition, and to 2 interventions - of which Ketamine is the first listed.
NCT04781673 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT04781673 about?
NCT04781673 is a clinical study titled "Ketamine vs Lidocaine in Traumatic Rib Fractures". Rib fractures continue to be a common occurrence in trauma patients of all ages. Traumatic rib fractures can cause severe pain in patients and lead to shallow breathing and further complications such as the need for mechanical ventilation, hospital or ventilator associated pneumonia, atelectasis, an...
What is the current status of trial NCT04781673?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 74 participants. The study started on 2021-04-01. Estimated completion is 2026-07.
What conditions does trial NCT04781673 study?
This clinical trial studies the following conditions: Rib Fractures, Rib Fracture Multiple, Rib Trauma.
What interventions are being tested in trial NCT04781673?
The interventions under investigation include: Ketamine (DRUG), Lidocaine (DRUG).
Who is sponsoring clinical trial NCT04781673?
This trial is sponsored by Brittany Hoyte, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04781673 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rib Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
INTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures
RECRUITING · Phase 4
-
Cryo Rib Fracture Study
RECRUITING · Phase 4
-
Analgesic Techniques for Rib Fractures
ACTIVE NOT RECRUITING · Phase 4
-
Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients
COMPLETED · Phase 4
-
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
COMPLETED · Phase 4
-
Blue Light as an Anti-inflammatory and Analgesic Strategy in Thoracic Trauma
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.